The Consortium for iNKT Research and Therapy (CiRT) is a coalition of investigators with interests in iNKT research and clinical translation. The CiRT aims to further the development of iNKT-based technologies, including cell and gene therapies to improve the outcomes of cancers, organ and bone marrow transplantation, infectious diseases and autoimmune disorders.